Day: August 12, 2020

Isabel Fernandez to step down from ING Management Board Banking as of 31 December 2020ING announced today that Isabel Fernandez, member of the Management Board Banking and head of ING Wholesale Banking will leave ING to continue her career outside the company. She will stay on until 31 December 2020 to facilitate an orderly transition to her successor, once selected. Further announcements on succession will be made as and when appropriate.Isabel joined ING and became a member of the Management Board in 2016, becoming head of Wholesale Banking in November of that year. Before joining ING, Isabel held various leadership roles at General Electric and GE Capital, including CEO of Structured Finance Media & Technology, CEO of Global Bank Loans and Chief Commercial Officer of GE Company.Steven van Rijswijk, CEO of ING said: “We’re grateful...

PRESS RELEASE12 August 2020Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced a conference call and webcast presentation regarding its recent directed share issue generating gross proceeds of USD 65 million (approximately SEK 567 million).The event will take place on Friday August 14th at 2 p.m. CET and will feature a presentation by Saniona’s management team to discuss the strategy and rationale for the financing, as well as an update on Saniona’s advancement of its late-stage clinical trials with Tesomet in two rare eating disorders, hypothalamic obesity (HO) and Prader Willi Syndrome (PWS), as well as progress building its U.S.-based organization in support of these programs.VIDEO DETAILShttps://abgsc.webex.com/abgsc/onstage/g.php?MTID=e7fd1a20a6a1661b83500532c896d7dd0Event...

PRESSMEDDELANDE12 augusti 2020Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att ett konferenssamtal och en webbsänd presentation ska hållas med anledning av företagets nyligen genomförda riktade nyemission, som tillförde bolaget 65 MUSD brutto (cirka 567 miljoner kronor).Under evenemanget, som äger rum fredagen den 14 augusti kl. 14:00 CET, kommer Sanionas ledningsgrupp att diskutera strategin och bakgrunden för emissionen. Man kommer även att ge en uppdatering om hur Saniona avancerar sina kliniska läkemedelsprövningar i sen fas av Tesomet mot två sällsynta ätstörningar, hypotalamisk fetma (HO) och Prader-Willis syndrom (PWS), och om hur uppbyggnaden av den USA-baserade organisation som ska understödja dem fortskrider.VIDEOANSLUTNINGhttps://abgsc.webex.com/abgsc/onstage/g.php?MTID=e7fd1a20a6a1661b83500532c896d7dd0Evenemangsnummer:...

12 August 2020Continued significant improvements in back year claims drive positive Admiral Group results for H1 2020Admiral Group plc results for the six months ended 30 June 20202020 Interim Results Highlights*1Alternative Performance Measures – refer to the end of the report for definition and explanation*2Group Turnover in H1 2020 presented net of the ‘Stay at Home’ premium refund issued to UK motor insurance customers of £97 million. Refer to the Alternative Performance Measures section at the end of this report for further explanation.Over 10,000 staff each receive free shares worth up to £1,800 under the employee share scheme based on the interim 2020 results.Comment from David Stevens, Group Chief Executive Officer“A year ago I described our results as ‘frankly a bit dull’. With the benefit of hindsight there’s a lot to...

Solar performed well in Q2 despite the challenges brought about by the COVID-19 pandemic. We reiterate our original EBITA guidance for 2020.CEO Jens Andersen says:“Solar’s agile and digital business model has proved itself during the COVID-19 pandemic. We have been able to serve our customers and maintain our delivery performance, and we will continue to invest in our digital transformation.We continue our journey towards improved profitability, delivering a 35% EBITA increase in Q2 despite a lower revenue compared to Q2 2019.We are pleased to reiterate our original EBITA guidance despite the fact that we expect a quarter of a billion Danish kroner lower revenue in H2 2020 compared to H2 2019. We owe this to our gross profit margin initiatives, efficiency gains and cost containment.”Key financial messagesDue to improved gross profit...

Solar klarede sig godt i Q2 på trods af de udfordringer, som COVID-19-pandemien bragte med sig. Vi gentager vores oprindelige forventninger til EBITA for 2020.CEO Jens Andersen udtaler:”Solars agile og digitale forretningsmodel har vist sit værd under COVID-19-pandemien. Vi har været i stand til at betjene vores kunder og opretholde vores høje leveringsevne. Samtidig fortsætter vores investeringer i den digitale transformation uændret.Vi fortsætter vores rejse mod forbedret lønsomhed og leverer en stigning i EBITA på 35% i Q2 på trods af en lavere omsætning end i Q2 2019.Vi er meget tilfredse med at kunne gentage vores oprindelige forventninger til EBITA, selvom vi faktisk forventer en kvart milliard kroner lavere omsætning i H2 2020 end i H2 2019. Dette skyldes vores bruttoavanceinitiativer, effektiviseringsgevinster samt stram styring...

Completed treatment phase of pivotal EMERGE™ Phase 3 efficacy trial of STS101 as planned and remain on track to report top-line results in late September or early October 2020Initiated patient enrollment in ASCEND™ Phase 3 open-label safety trial of STS101 Cash, cash equivalents and marketable securities of $93.7 million as of June 30, expected to provide cash runway through end of 2021 and planned STS101 NDA filing in Q4 2021SOUTH SAN FRANCISCO, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today summarized recent business progress  and reported financial results for the second quarter ended June 30, 2020.“As evidenced by the completion of the treatment phase of our Phase 3 EMERGE efficacy trial and the recent initiation of patient enrollment in...

Company Announcement no. 37/2020Q2 2020 Highlights:Reported revenue was EUR 106.7m, a decrease of 2.6% when compared with Q2 2019.EBIT was EUR 26.0m and EBIT margin was 24.4% compared with the strong EBIT of EUR 32.3m and EBIT margin of 29.5% in Q2 2019.In Q2 2020, one new SimCorp Dimension and two new SimCorp Coric orders were signed. For two of the new orders, order intake and revenue recognition have been deferred until certain conditions are met.Order intake was EUR 16.9m, a decrease of EUR 5.7m or 25% compared with Q2 2019.Free cash flow was EUR 20.4m, an increase of 8% when compared with Q2 2019.H1 2020 Highlights:Reported revenue of EUR 209.7m was at the same level as in H1 2019. Measured in local currencies, and excluding M&A activities, the organic revenue declined by 3.2% when compared with H1 2019.EBIT was EUR 43.5m compared...

Agility® Fuel Solutions (Agility), a business of Hexagon Composites and a leading global provider of clean fuel solutions for medium- and heavy-duty commercial vehicles, received a substantial order from longtime customer Anheuser-Busch. Over 180 new trucks equipped with Agility’s ProCab® 175 CNG Fuel Systems will be joining the fleet. The estimated total value of the order is over USD 8.0 million (approx. NOK 72 million).In 2014 and 2015, Anheuser-Busch converted 160 diesel-fueled trucks in Houston and St. Louis to fleets powered by compressed natural gas (CNG) engines. As the next step to achieve their 2025 sustainability goal of reducing carbon emissions across their value chain by 25% by 2025, the brewer will be expanding this fleet and investing in technology to transition to cleaner-burning renewable natural gas.“Innovation in the...

Company announcement no. 19/2020PICKUP IN DEMAND FASTER THAN EXPECTED